{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T05:27:34Z","timestamp":1773466054119,"version":"3.50.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T00:00:00Z","timestamp":1722988800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T00:00:00Z","timestamp":1722988800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"DOI":"10.1186\/s12887-024-04971-0","type":"journal-article","created":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T04:05:33Z","timestamp":1723003533000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Opioid and benzodiazepine requirements in critically ill post-surgical children with down syndrome: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"24","author":[{"given":"Shaimaa","family":"Alsulami","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashjan","family":"Alghanem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renad","family":"AlShuraim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khalid","family":"Al Sulaiman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omer Ahmed","family":"Abdelwahab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Aljohani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hadeel","family":"Alkofide","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mashael","family":"AlFaifi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tarek","family":"Hazwani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ohoud","family":"Aljuhani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,8,7]]},"reference":[{"key":"4971_CR1","unstructured":"What is Down Syndrome? - Down Syndrome Resource Foundation. (2023, November 1). Down Syndrome Resource Foundation. https:\/\/www.dsrf.org\/resources\/information\/what-is-down-syndrome\/"},{"issue":"18","key":"4971_CR2","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1002\/bdr2.1589","volume":"111","author":"CT -Mai","year":"2019","unstructured":"Mai CT, Isenburg JL, Canfield MA, Meyer RE, Correa A, Alverson CJ, Lupo PJ, Riehle-Colarusso T, Cho SJ, Aggarwal D, Kirby RS. October 3). National population\u2010based estimates for major birth defects, 2010\u20132014. Birth Defects Res. 2019;111(18):1420\u201335. https:\/\/doi.org\/10.1002\/bdr2.1589. Tubman, T. R., Shields, M. D., Craig, B. G.","journal-title":"Birth Defects Res"},{"key":"4971_CR3","doi-asserted-by":"publisher","unstructured":"Mulholland HC, Nevin NC. (1991, June 15). Congenital heart disease in Down\u2019s syndrome: two year prospective early screening study. BMJ, 302(6790), 1425\u20131427.https:\/\/doi.org\/10.1136\/bmj.302.6790.1425","DOI":"10.1136\/bmj.302.6790.1425"},{"key":"4971_CR4","doi-asserted-by":"publisher","unstructured":"Antonarakis SE, Skotko BG, Rafii MS, Strydom A, Pape SE, Bianchi DW, Sherman SL, Reeves RH. February 6). Down syndrome. Nat Reviews Disease Primers. 2020;6(1). https:\/\/doi.org\/10.1038\/s41572-019-0143-7.","DOI":"10.1038\/s41572-019-0143-7"},{"issue":"24","key":"4971_CR5","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1056\/nejmra1706537","volume":"382","author":"MJ -Bull","year":"2020","unstructured":"Bull MJ. Down syndrome. N Engl J Med. 2020;382(24):2344\u201352. https:\/\/doi.org\/10.1056\/nejmra1706537.","journal-title":"N Engl J Med"},{"key":"4971_CR6","doi-asserted-by":"publisher","unstructured":"Barnes S, Yaster M, Kudchadkar SR. (2016, May 1). Pediatric Sedation Management. Pediatrics in Review, 37(5), 203\u2013212. https:\/\/doi.org\/10.1542\/pir.2014-0116","DOI":"10.1542\/pir.2014-0116"},{"key":"4971_CR7","doi-asserted-by":"publisher","unstructured":"Haydar TF, Reeves RH. Trisomy 21 and early brain development. Trends Neurosci. 2012, February;35(2):81\u201391. https:\/\/doi.org\/10.1016\/j.tins.2011.11.001.","DOI":"10.1016\/j.tins.2011.11.001"},{"issue":"5","key":"4971_CR8","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1002\/med.21954","volume":"43","author":"A -Shaikh","year":"2023","unstructured":"Shaikh A, Li Y, Lu J. Perspectives on pain in Down Syndrome. Med Res Rev. 2023b;43(5):1411\u201337. https:\/\/doi.org\/10.1002\/med.21954.","journal-title":"Med Res Rev"},{"key":"4971_CR9","doi-asserted-by":"publisher","unstructured":"SCOTT -GAKHALB, C. S., MACNAB AJ. Comparison of morphine requirements for sedation in Down\u2019s syndrome and non-down\u2019s patients following paediatric cardiac surgery. Pediatr Anesth. 1998, May;8(3):229\u201333. https:\/\/doi.org\/10.1046\/j.1460-9592.1998.00764.x.","DOI":"10.1046\/j.1460-9592.1998.00764.x"},{"issue":"9","key":"4971_CR10","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1097\/PCC.0b013e31829f5d9d","volume":"14","author":"SL -Van Driest","year":"2013","unstructured":"Van Driest SL, Shah A, Marshall MD, Xu H, Smith AH, McGregor TL, Kannankeril PJ. November). Opioid use after cardiac surgery in Children with Down Syndrome*. Pediatr Crit Care Med. 2013;14(9):862\u20138.","journal-title":"Pediatr Crit Care Med"},{"key":"4971_CR11","doi-asserted-by":"publisher","unstructured":"Goot BH, Kaufman J, Pan Z, Bourne DWA, Hickey F, Twite M, Galinkin J, Christians U, Zuk J, da Cruz EM. Morphine Pharmacokinetics in Children with Down Syndrome following cardiac surgery. Pediatr Crit Care Med. 2018, May;19(5):459\u201367. https:\/\/doi.org\/10.1097\/pcc.0000000000001537.","DOI":"10.1097\/pcc.0000000000001537"},{"key":"4971_CR12","doi-asserted-by":"publisher","unstructured":"Valkenburg AJ, Calvier EAM, van Dijk M, Krekels EHJ, O\u2019Hare BP, Casey WF, Math\u00f4t RAA, Knibbe CAJ, Tibboel D, Breatnach CV. Pharmacodynamics and pharmacokinetics of Morphine after Cardiac surgery in children with and without Down Syndrome. Pediatr Crit Care Med. 2016, October;17(10):930\u20138. https:\/\/doi.org\/10.1097\/pcc.0000000000000904.","DOI":"10.1097\/pcc.0000000000000904"},{"key":"4971_CR13","doi-asserted-by":"publisher","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, Chou R, Glanville J, Grimshaw JM, Hr\u00f3bjartsson A, Lalu MM, Li T, Loder EW, Mayo-Wilson E, McDonald S, Moher D. March 29). The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;71. https:\/\/doi.org\/10.1136\/bmj.n71.","DOI":"10.1136\/bmj.n71"},{"key":"4971_CR14","doi-asserted-by":"publisher","unstructured":"Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan\u2014a web and mobile app for systematic reviews. Syst Reviews. 2016, December;5(1). https:\/\/doi.org\/10.1186\/s13643-016-0384-4.","DOI":"10.1186\/s13643-016-0384-4"},{"key":"4971_CR15","unstructured":"Equianalgesic Doses of Opioid Analgesics, Manual MSD. Retrieved November 29, 2023, from https:\/\/www.msdmanuals.com\/en-jp\/professional\/multimedia\/table\/equianalgesic-doses-of-opioid-analgesics"},{"key":"4971_CR16","unstructured":"Morphine 10\u00a0mg\/mL injection, 1\u00a0mg\/mL oral solution. South Australian Neonatal Medication Guidelines. Retrieved November 29. 2023, from https:\/\/www.sahealth.sa.gov.au\/wps\/wcm\/connect\/public+content\/sa+health+internet\/clinical+resources\/clinical+programs+and+practice+guidelines\/womens+and+babies+health\/neonatal+medication+guidelines\/neonatal+medication+guidelines"},{"key":"4971_CR17","unstructured":"Kane SP. Benzodiazepine Equivalents Conversion Calculator - ClinCalc.com. https:\/\/clincalc.com\/Benzodiazepine\/"},{"key":"4971_CR18","unstructured":"Wells, George & Shea, Beverley & O\u2019Connell, D & Peterson, je & Welch, Vivian & Losos,M & Tugwell, Peter. (2000). The Newcastle\u2013Ottawa Scale (NOS) for Assessing the Quality of Non-Randomized Studies in Meta-Analysis"},{"issue":"6","key":"4971_CR19","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1177\/0962280216669183","volume":"27","author":"D -Luo","year":"2016","unstructured":"Luo D, Wan X, Liu J, Tong T. Optimally estimating the sample mean from the sample size, median, mid-range, and\/or mid-quartile range. Stat Methods Med Res. 2016;27(6):1785\u2013805. https:\/\/doi.org\/10.1177\/0962280216669183.","journal-title":"Stat Methods Med Res"},{"key":"4971_CR20","doi-asserted-by":"publisher","unstructured":"Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range. BMC Med Res Methodol. 2014, December;14(1). https:\/\/doi.org\/10.1186\/1471-2288-14-135.","DOI":"10.1186\/1471-2288-14-135"},{"key":"4971_CR21","doi-asserted-by":"publisher","unstructured":"Vogel ER, Staffa SJ, DiNardo JA, Brown ML. Dosing of opioid medications during and after Pediatric Cardiac surgery for children with Down Syndrome. J Cardiothorac Vasc Anesth. 2022, January;36(1):195\u20139. https:\/\/doi.org\/10.1053\/j.jvca.2021.08.019.","DOI":"10.1053\/j.jvca.2021.08.019"},{"key":"4971_CR22","doi-asserted-by":"publisher","unstructured":"Valkenburg A, van Dijk M, de Leeuw T, Meeussen C, Knibbe C, Tibboel D. Anaesthesia and postoperative analgesia in surgical neonates with or without Down\u2019s syndrome: is it really different? Br J Anaesth. 2012, February;108(2):295\u2013301. https:\/\/doi.org\/10.1093\/bja\/aer421.","DOI":"10.1093\/bja\/aer421"},{"issue":"Supplement","key":"4971_CR23","doi-asserted-by":"publisher","first-page":"97A","DOI":"10.1097\/00003246-199801001-00263","volume":"26","author":"AP -Ellis","year":"1998","unstructured":"Ellis AP, Kanter RK, Requirements for post-operative analgesics and sedatives in children with down syndrome. January. Dosing. Crit Care Med. 1998;26(Supplement):97A. https:\/\/doi.org\/10.1097\/00003246-199801001-00263.","journal-title":"Crit Care Med"},{"key":"4971_CR24","doi-asserted-by":"publisher","unstructured":"Borland LM, Colligan J, Brandom BW. (2004, August 26). Frequency of anesthesia-related complications in children with Down syndrome under general anesthesia for noncardiac procedures. Pediatric Anesthesia, 14(9), 733\u2013738. https:\/\/doi.org\/10.1111\/j.1460-9592.2004.01329.x","DOI":"10.1111\/j.1460-9592.2004.01329.x"},{"key":"4971_CR25","doi-asserted-by":"publisher","unstructured":"Hennequin M, Morin C, Feine J. Pain expression and stimulus localisation in individuals with Down\u2019s syndrome. Lancet. 2000, December;356(9245):1882\u20137. https:\/\/doi.org\/10.1016\/s0140-6736(00)03259-1.","DOI":"10.1016\/s0140-6736(00)03259-1"}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-024-04971-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12887-024-04971-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-024-04971-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T04:06:13Z","timestamp":1723003573000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpediatr.biomedcentral.com\/articles\/10.1186\/s12887-024-04971-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,7]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["4971"],"URL":"https:\/\/doi.org\/10.1186\/s12887-024-04971-0","relation":{},"ISSN":["1471-2431"],"issn-type":[{"value":"1471-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,7]]},"assertion":[{"value":"19 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"504"}}